Conference Reports for NATAP

Conference on Retroviruses and Opportunistic Infections (CROI) February 22-25, 2016, Boston MA Back

MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel       Reported by Jules Levin CROI 2016 Feb 22-24 Boston   Ross D. Cranston MB ChB MD FRCP Associate Professor of Medicine University of Pittsburgh For the MTN-017 Protocol Team   WEBCAST link: http://www.croiwebcasts.org/console/player/29583?mediaType=audio&